Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CeFCiD) : an open-label phase II randomised trial (AIO/IAG-KHT trial 1108)

Klinghammer, K.; Gauler, T.; Dietz, A.; Gruenwald, V.; Stoehlmacher, J.; Knipping, S.; Schroeder, M.; Guntinas-Lichius, O.; Frickhofen, N.; Lindeman, H. -W.; Fietkau, R.; Haxel, B.; Grosse-Thie, C.; Maschmeyer, G.; Zipfel, M.; Martus, P.; Knoedler, M.; Keilholz, U.

dc.contributor.author	Martus, Peter
dc.date.accessioned	2020-08-11T07:07:36Z
dc.date.available	2020-08-11T07:07:36Z
dc.date.issued	2019
dc.identifier.issn	1879-0852
dc.identifier.uri	http://hdl.handle.net/10900/104648
dc.language.iso	en	de_DE
dc.publisher	Elsevier Sci Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.ejca.2019.08.018	de_DE
dc.subject.ddc	610	de_DE
dc.title	Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CeFCiD) : an open-label phase II randomised trial (AIO/IAG-KHT trial 1108)	de_DE
dc.type	Article	de_DE
utue.quellen.id	20200409032300_00682
utue.publikation.seiten	53-60	de_DE
utue.personen.roh	Klinghammer, K.
utue.personen.roh	Gauler, T.
utue.personen.roh	Dietz, A.
utue.personen.roh	Gruenwald, V.
utue.personen.roh	Stoehlmacher, J.
utue.personen.roh	Knipping, S.
utue.personen.roh	Schroeder, M.
utue.personen.roh	Guntinas-Lichius, O.
utue.personen.roh	Frickhofen, N.
utue.personen.roh	Lindeman, H. -W.
utue.personen.roh	Fietkau, R.
utue.personen.roh	Haxel, B.
utue.personen.roh	Grosse-Thie, C.
utue.personen.roh	Maschmeyer, G.
utue.personen.roh	Zipfel, M.
utue.personen.roh	Martus, P.
utue.personen.roh	Knoedler, M.
utue.personen.roh	Keilholz, U.
dcterms.isPartOf.ZSTitelID	European Journal of Cancer	de_DE
dcterms.isPartOf.ZS-Volume	122	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE